Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in advanced triple-negative breast cancer patients
Jieqiong Liu, Ying Li, Qian Li, Dandan Liang, Quanren Wang, Qiang Liu
Topics & Concepts
ApatinibMedicineInternal medicineBreast cancerTriple-negative breast cancerCD8OncologyTumor-infiltrating lymphocytesImmunotherapyTumor microenvironmentCancerImmune systemGastroenterologyImmunologyCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesImmunotherapy and Immune Responses